Standout Papers

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020) 2020 2026 2022 2024277
  1. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020) (2020)
    Liling Huang, Shiyu Jiang et al. Journal of Hematology & Oncology

Immediate Impact

1 by Nobel laureates 17 from Science/Nature 71 standout
Sub-graph 1 of 20

Citing Papers

NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
1 intermediate paper

Works of Liling Huang being referenced

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020 Standout

Author Peers

Author Last Decade Papers Cites
Liling Huang 448 190 206 466 42 1.2k
Weiwei Mao 551 80 138 321 46 1.1k
Yi Cao 766 144 416 339 45 1.5k
Caiqin Zhang 337 105 129 564 48 1.2k
Vidal Fey 938 140 228 269 33 1.5k
Ravi Ramesh Pathak 576 80 157 231 37 1.0k
Lynn M. Knowles 683 128 316 273 34 1.3k
Thomas Lehmann 739 75 189 307 39 1.7k
Giuseppe Lattanzio 411 138 285 271 33 1.1k
Dadong Zhang 524 77 139 554 41 1.3k
Matthew J. McKay 601 75 106 194 54 1.2k

All Works

Loading papers...

Rankless by CCL
2026